Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UNISHAPE-1 phase 3 study of UBT251 injection in adults with overweight or obesity
CTR20262251Phase 3Active
- Sponsor
- The United Laboratories International Holdings
- Start
- Sep 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of UBT251 in obesity, Overweight, sponsored by The United Laboratories International Holdings. Started Sep 2026; status: active.
02
Drugs
UBT251
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20262251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262251.